Bank Of New York Mellon Corp Celldex Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$34.78 - $47.43 $5.74 Million - $7.83 Million	165,068 New	165,068 $5.94 Billion
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $4.69 Million - $7.67 Million	168,989 New	168,989 $7.53 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $299,571 - $495,811	13,197 Added 8.82%	162,782 $4.58 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $84,419 - $153,724	-4,118 Reduced 2.68%	149,585 $4.03 Million
Q1 2022 May 11, 2022	BUY	$27.64 - $39.32 $6,716 - $9,554	243 Added 0.16%	153,703 $5.24 Million
Q4 2021 Feb 11, 2022	SELL	$35.68 - $56.27 $688,124 - $1.09 Million	-19,286 Reduced 11.16%	153,460 $5.93 Million
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $1.63 Million - $3.15 Million	56,311 Added 48.36%	172,746 $9.33 Million
Q2 2021 Aug 11, 2021	BUY	$20.71 - $35.37 $1.39 Million - $2.38 Million	67,182 Added 136.4%	116,435 $3.89 Million
Q1 2021 May 13, 2021	SELL	$16.19 - $29.91 $36,994 - $68,344	-2,285 Reduced 4.43%	49,253 $1.01 Million
Q4 2020 Feb 09, 2021	BUY	$14.99 - $22.75 $490,008 - $743,674	32,689 Added 173.43%	51,538 $902,000
Q3 2020 Nov 12, 2020	BUY	$9.65 - $15.19 $181,892 - $286,316	18,849 New	18,849 $279,000
Q2 2019 Aug 12, 2019	SELL	$2.43 - $5.09 $62,016 - $129,901	-25,521 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$3.45 - $10.35 $88,047 - $264,142	25,521 New	25,521 $126,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.